Public, NASDAQ:HNAB
NASDAQ Global Market
Video Interview: Steven R. Deitcher, MD, President and CEO, Hana Biosciences
Date: Fri, 19 Sep 2008 15:18:05 GMT
Tags:
Video Interview: Steven R. Deitcher, MD, President and CEO, Hana Biosciences
Trading Markets (press release) - Sep 19, 2008
Trading Markets (press release) - Sep 19, 2008
NEW YORK , Sep 19 , 2008 ( GlobeNewswire via COMTEX ) - - HNAB | Quote | Chart | News | PowerRating - - Veteran business journalist Sasha Salama joins Steven R . Deitcher , MD , President and ...
Hana Biosciences's leukemia study to proceed to full enrollment
Date: Wed, 10 Sep 2008 17:05:25 GMT
Tags:
Hana Biosciences's leukemia study to proceed to full enrollment
Trading Markets (press release) - Sep 10, 2008
Trading Markets (press release) - Sep 10, 2008
Sep 10 , 2008 ( Datamonitor via COMTEX ) - - HNAB | Quote | Chart | News | PowerRating - - Hana Biosciences has announced that the pre - specified response criteria to proceed to full enrollment ...
Hana Biosciences' rALLy Clinical Trial of Marqibo Meets Response Criteria to Advance to Full Enrollment
Date: Tue, 09 Sep 2008 21:38:14 GMT
Tags:
Hana Biosciences' rALLy Clinical Trial of Marqibo Meets Response Criteria to Advance to Full Enrollment
PipelineReview.com (press release) - Sep 9, 2008
PipelineReview.com (press release) - Sep 9, 2008
SOUTH SAN FRANCISCO , CA , USA | September 9 , 2008 | Hana Biosciences ( Nasdaq : HNAB ) , a biopharmaceutical company focused on strengthening the foundation of cancer care , today announced ...
Hana Biosciences' rALLy Clinical Trial of Marqibo Meets Response Criteria to Advance to Full Enrollment
Date: Tue, 09 Sep 2008 11:23:35 GMT
Tags:
Hana Biosciences' rALLy Clinical Trial of Marqibo Meets Response Criteria to Advance to Full Enrollment
MarketWatch - Sep 9, 2008
MarketWatch - Sep 9, 2008
, , ) , a biopharmaceutical company focused on strengthening the foundation of cancer care , today announced that the pre - specified response criteria to proceed to full enrollment of 56 patients ...
Hana Biosciences a Bit Early
Date: Fri, 05 Sep 2008 11:32:59 GMT
Tags:
Hana Biosciences a Bit Early
Trading Markets (press release) - Sep 5, 2008
Trading Markets (press release) - Sep 5, 2008
Sep 05 , 2008 ( Zacks Investment Research via COMTEX ) - - HNAB | Quote | Chart | News | PowerRating - - Hana Biosciences Inc . ( HNAB ) has a relatively diversified portfolio but all candidates ...
Video Interview: Steven R. Deitcher, MD, President and CEO, Hana Biosciences (GlobeNewswire)
Date: Fri, 19 Sep 2008 15:00:00 Etc/GMT
Tags:
HANA BIOSCIENCES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
Date: Wed, 10 Sep 2008 10:02:10 Etc/GMT
Tags:
Hana Biosciences' rALLy Clinical Trial of Marqibo Meets Response Criteria to Advance to Full Enrollment (GlobeNewswire)
Date: Tue, 9 Sep 2008 11:05:00 Etc/GMT
Tags:
SOUTH SAN FRANCISCO, Calif., Sept. 9, 2008 -- Hana Biosciences , a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the pre-specified response criteria to proceed to full enrollment of 56 patients has been achieved in its pivotal clinical trial of Marqibo (vincristine sulfate injection, OPTISOME) for the treatment of adult acute lymphoblastic leukemia in second relapse.
Hana Biosciences a Bit Early (Zacks.com)
Date: Thu, 4 Sep 2008 16:29:37 Etc/GMT
Tags:
HANA BIOSCIENCES INC Financials (EDGAR Online Financials)
Date: Wed, 20 Aug 2008 13:04:24 Etc/GMT
Tags: